Sanara MedTech (NASDAQ:SMTI) PT Lowered to $44.00

Sanara MedTech (NASDAQ:SMTI – Get Free Report) had its price objective cut by equities researchers at Cantor Fitzgerald from $49.00 to $44.00 in a research note issued to investors on Wednesday, Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Cantor Fitzgerald’s price target would indicate a potential upside of 18.92% from […]

Related Keywords

California ,United States ,Sanara Medtech ,Barclays Plc ,Sanara Medtech Inc ,Cantor Fitzgerald ,Tower Research Capital ,Get Free Report ,Research Capital ,Capital Management ,California State Teachers Retirement System ,Medtech Inc ,Activated Collagen ,Antimicrobial Skin ,Wound Cleanser ,Antimicrobial Wound Gel ,Wound Irrigation ,Sanara Medtech Daily ,Nasdaq Smti ,Asmti ,Medical ,Lower Price Target ,